We bargain bought Ahealth mildly due to its growing market shares and valuation

Apex Healthcare has recently gaining market share in Malaysia pharmaceutical industry.  As of the current down turn, its price has adjusted back to RM 2.50 level compare to a high of around RM 3.3, current PE is around 7-8 times and Forecast year around 6-7 times easily.

I like Tom Peters’ theory, if i am not remember wrongly.  “Management by walking around”  That also a key factor to always give boost to us if we confident to see that Apex’s products have been growing seen in many clinics.